SCHEMBL5783370

SCHEMBL5783370

[CH2]C(C)(O)CCc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.44
ALDH1A1 P00352 3/20 0.42
ALOX12 P18054 2/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
CASP1 P29466 1/20 0.41
HSD17B10 Q99714 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MAPT P10636 2/20 0.41
POLB P06746 1/20 0.41
TAAR1 Q96RJ0 4/20 0.40
FDPS P14324 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
ATM Q13315 1/20 0.40
KEAP1 Q14145 1/20 0.40
SLC6A2 P23975 1/20 0.40
MEN1 O00255 2/20 0.40
HTT P42858 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL251220 0.82 TDP1 (0.48) TDP1ALDH1A1ALOX12HPGDALOX15
SCHEMBL272368 0.82 TDP1 (0.48) TDP1ALDH1A1ALOX12HPGDALOX15
SCHEMBL28112277 0.82 TDP1 (0.48) TDP1ALDH1A1ALOX12HPGDALOX15
SCHEMBL3461930 0.82 ALDH1A1 (0.44) TDP1ALDH1A1ALOX12HPGDALOX15
SCHEMBL11871937 0.81 CYP1A2 (0.45) TDP1ALDH1A1HPGDALOX15NPC1
SCHEMBL27477280 0.80 ALDH1A1 (0.42) TDP1ALDH1A1ALOX12HPGDALOX15
Water SCHEMBL27475250 0.80 TDP1 (0.46) TDP1ALDH1A1ALOX12HPGDALOX15
Ammonia Solution, Strong SCHEMBL2333633 0.80 TDP1 (0.46) TDP1ALDH1A1ALOX12HPGDALOX15
SCHEMBL11224549 0.79 TDP1 (0.50) TDP1ALDH1A1ALOX12HPGDALOX15
SCHEMBL11661906 0.79 TDP1 (0.41) TDP1ALDH1A1ALOX12HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101965186-A Compositions and methods for inhibiting cytochrome p450 2d6 SEQUOIA PHARMACEUTICALS INC 2011-02-02 CN disclosed
CN-101674822-A compositions and methods for inhibiting cytochrome p450 SEQUOIA PHARMACEUTICALS INC 2010-03-17 CN disclosed
EP-1709037-A2 HIV PROTEASE INHIBITING SULFONAMIDES ABBOTT LABORATORIES (US) 2006-10-11 EP disclosed
WO-2005061450-A2 HIV PROTEASE INHIBITING SULFONAMIDES ABBOTT LABORATORIES (US) 2005-07-07 WO disclosed